Edition:
United Kingdom

Consort Medical PLC (CSRT.L)

CSRT.L on London Stock Exchange

1,178.00GBp
24 Sep 2018
Change (% chg)

-44.00 (-3.60%)
Prev Close
1,222.00
Open
1,200.00
Day's High
1,268.00
Day's Low
1,178.00
Volume
4,175
Avg. Vol
14,214
52-wk High
1,779.00
52-wk Low
1,040.00

Chart for

About

Consort Medical PLC is a contract development and manufacturing organization (CDMO). The Company's principal activities include designing, development and manufacture of medical drug delivery devices and services for the pharmaceutical industry. The Company operates through two segments: Bespak and Aesica. Bespak's core business... (more)

Overall

Beta: -0.08
Market Cap(Mil.): £537.15
Shares Outstanding(Mil.): 49.28
Dividend: 13.21
Yield (%): --

Financials

  CSRT.L Industry Sector
P/E (TTM): 23.81 32.30 32.76
EPS (TTM): 0.46 -- --
ROI: 8.27 13.94 14.61
ROE: 10.73 16.79 16.33

Consort, Opiant to develop nasal spray for opioid overdose treatment

Britain's Consort Medical Plc said on Monday it had agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc.

10 Sep 2018

UPDATE 1-Consort, Opiant to develop nasal spray for opioid overdose treatment

Sept 10 Britain's Consort Medical Plc said on Monday it had agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc.

10 Sep 2018

Consort and Opiant to work on nasal spray overdose treatment

Sept 10 Consort Medical Plc has agreed to develop a nasal spray for treating opioid overdoses with specialty pharmaceutical company Opiant Pharmaceuticals Inc .

10 Sep 2018

Earnings vs. Estimates